Rosuvastatin calcium impurity E [EP](2226413-61-0)
- Name: Rosuvastatin calcium impurity E [EP]
- Synonyms:7DWS9BK2LZ;2226413-61-0;Rosuvastatin calcium impurity E [EP];(3R,5S,6E)-7-(4-(4-Fluorophenyl)-2-(((2-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)pyrimidin-5-yl)-2-hydroxyethyl)sulfonyl)(methyl)amino)-6-(1-methylethyl)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid;(3R,5S,E)-7-(4-(4-Fluorophenyl)-2-(2-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-2-hydroxy-N-methylethylsulfonamido)-6-isopropylpyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid;6-Heptenoic acid, 7-(4-(4-fluorophenyl)-2-(((2-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-2-hydroxyethyl)sulfonyl)methylamino)-6-(1-methylethyl)-5-pyrimidinyl)-3,5-dihydroxy-, (3R,5S,6E)-;UNII-7DWS9BK2LZ;ROSUVASTATIN CALCIUM IMPURITY E [EP IMPURITY];(E,3R,5S)-7-[4-(4-fluorophenyl)-2-[[2-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-2-hydroxyethyl]sulfonyl-methylamino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid
- Molecular Formula:C38H46F2N6O9S2
- Molecular Weight:832.9
- CAS Registry Number:2226413-61-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.2226413-61-0 Rosuvastatin EP Impurity E
Assay:鈮?5% Storage:Store at -20掳C Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 933701-68-9/N-Methyl-1-[2-(2-thienyl)-1,3-thiazol-4-YL]methanamine
- 1160263-07-9/6-Chloro-2-(5-methyl-2-thienyl)quinoline-4-carbonyl chloride
- 1242260-60-1/Ethyl 4-bromo-8-methoxyquinoline-3-carboxylate
- 1256790-33-6/5-Bromo-4-methoxy-2-(trifluoromethyl)pyridine
- 1099598-25-0/1,3-Dichloro-2-(2,2,2-trifluoroethyl)benzene
- 21328-27-8/Ethyl spiro[cyclopropane-1,9'-fluorene]-2-carboxylate
- 39226-89-6/1,2,3,4 tetrahydro-5-Methoxy-N-Methyl 2-napthalenaMine HCl
- 1805773-37-8/N-(Difluoromethylthio)phthalimide
- 1204811-31-3/4,8-Dichloro-6-methyl-2-propylquinoline hydrochloride
- 1219406-60-6/6-Amino-5,6-dihydroimidazo[1,2-a]pyrimidin-7(8H)-one
- 10109-66-7/(8S,13S,14S,17R)-3,4-dimethoxy-13-methyl-17-prop-2-enyl-2,3,4,6,7,8,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-ol
- 1310404-13-7/2-(3-Methylpiperidin-1-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
- 1185304-13-5/4-(tert-Butyl)phenyl 4-piperidinylmethyl ether hydrochloride
- 1220032-97-2/3-[(4-Chloro-2-nitrophenoxy)methyl]piperidine hydrochloride
- 1156508-87-0/1,3-Bis(4-nitrophenyl)urea-d8
- 1245647-86-2/1-(((tert-Butoxycarbonyl)oxy)carbonyl)pyrrolidine-3-carboxylic acid
- 207233-86-1/(4-Benzyloxy-benzyl)-hydrazine
- 31981-26-7/8H-thieno[3,4-f][1]benzothiol-4-one
- 1306604-40-9/Imidazo[1,2-a]pyridin-6-amine hydrochloride
- 2226413-61-0/Rosuvastatin calcium impurity E [EP]
- 1632444-57-5/2-Chloro-3-fluoro-4-nitrophenol
- 1187169-69-2/2-Chloro-5-(3,4-difluorobenzoyl)pyridine
- 910443-36-6/2-(2,3-Dimethylphenyl)-1-ethyl-5-oxopyrrolidine-3-carboxamide
- 853319-62-7/methyl (6-oxo-3-phenylpyridazin-1(6H)-yl)acetate
- 13292-32-5/[(9E,19E,21E)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-26-[(E)-(phenylhydrazinylidene)methyl]-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
- 1256627-72-1/2-chloro-N-(6-methyl-7-oxo-8,8a-dihydro-7H-[1,3]thiazolo[3,2-b][1,2,4]triazin-3-yl)acetamide
- 1363210-35-8/tert-Butyl 5-(hydroxymethyl)-2-azabicyclo[2.2.1]heptane-2-carboxylate
- 65758-31-8/1-Thia-4-azabicyclo[2.2.2]octan-1-ium bromide
- 515823-30-0/Tetramethylammonium trifluoromethanethiolate
- 1375415-82-9/Gemigliptin tartrate sesquihydrate